Q3 2025 ICON PLC Earnings Call Transcript
Key Points
- Icon PLC (ICLR) reported strong gross business awards totaling $3 billion, up mid-single digits year-over-year.
- Revenue increased both sequentially and year-over-year, driven by a strong therapeutic mix.
- The company executed $250 million in share buybacks during the quarter, bringing total repurchases to $750 million year-to-date.
- Icon PLC (ICLR) generated strong free cash flow of $334 million in the quarter and $687 million year-to-date.
- The company is focusing on deploying innovative technologies, including AI-enabled solutions, to enhance efficiency and predictability in clinical trials.
- Adjusted EBITDA margin decreased by 20 basis points sequentially to 19.4%, impacted by higher pass-through revenue mix.
- Net book-to-bill ratio was negatively affected by elevated cancellations of $900 million, consistent with previous quarter levels.
- The pricing environment remains competitive, particularly in large pharma, which may impact future margins.
- Pass-through revenues are expected to weigh on gross margins in the near term.
- Despite improvements in biotech funding, the environment remains mixed regarding the timelines for conversion of opportunities to awards and contracts.
Good day, and thank you for standing by. Welcome to the ICON PLC Q3 2025 earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your first speaker today, Kate Haven, VP of Investor Relations. Please go ahead.
Hello, and thank you for joining us on this call covering the quarter ended September 30, 2025. Also on the call today, we have our CEO, Barry Balfe; our CFO, Nigel Clerkin; and our former CEO and non-executive Board member, Steve Cutler.
I would like to note that this call is webcast and that there are slides available to download on our website to accompany today's call. Certain statements in today's call will be forward-looking statements. These statements are based on management's current expectations and information currently available, including current economic and industry conditions. Actual results may differ materially from those stated or implied by forward-looking
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
